AbbVie nears deal to buy Allergan for more than $60 billion: WSJ

AbbVie nears deal to buy Allergan for more than $60 billion: WSJ

FILE PHOTO: The Allergan logo is seen in this photo illustration in Singapore November 23, 2015. REUTERS/Thomas White/File Photo

(Reuters) – AbbVie Inc is nearing a deal to buy Botox-maker Allergan PLC for more than $60 billion, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

Both companies did not immediately respond to Reuters’ request for comment.

Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli

Related posts